Therapy Updates of 2024 Guidelines for the Diagnosis and Treatment of Heart Failure in China

VernacularTitle:《中国心力衰竭诊断和治疗指南2024》药物更新透视
Author: Juan WU ^{1
,

2} ; Ping LONG ; Lu ZENG ; Lu WANG ; Xuepeng GONG ; Anhua WEI
Author Information

1. 华中科技大学同济医学院附属同济医院药学部,武汉 430030
2. 泰康同济(武汉)医院药学部,武汉 430050
Keywords: Heart failure; Pharmacologic therapy; Guidelines
From: Herald of Medicine 2024;43(11):1718-1722
CountryChina
Language:Chinese
Abstract: Heart failure is a severe manifestation or advanced stage of various heart diseases,with high mortality and readmission rates.The 2024 guidelines for the diagnosis and treatment of heart failure,which are on the 2018 guidelines,combined with new evidence and China's national conditions,provide a comprehensive and systematic description and recommendation on the classification,diagnosis,prevention,treatment,comorbidity,and management of heart failure.This article reviewed the update of the therapeutic drugs section.